The Effectiveness of a Post-ICU Recovery Program on Relatives (RAPIT-II)

March 6, 2018 updated by: Janet Froulund Jensen, Holbaek Sygehus

The Effectiveness of a Post-ICU Recovery Program on Relatives to Patients Receiving Mechanically Ventilatory Support: Data Linked to RAPIT-I Investigation

Relatives of intensive care patients are at risk of developing symptoms of anxiety, depression and post-traumatic stress disorder resulting in impaired health-related quality of life (HRQOL). Recovery programs have been tested, but its effectiveness is sparse. The hypothesis is that relatives to former intensive care patients will improve their HRQOL one year after intensive care. We want to determine whether relatives to former intensive care patient's benefits from a recovery programme with improved HRQOL, Sense Of Coherence (SOC) and symptoms of anxiety, depression and PTSD compared to standard care one year after intensive care.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Relatives of intensive care patients are affected of critical illness with symptoms of anxiety, depression and post-traumatic stress disorder resulting in impaired mental health. Recovery programs aimed at patients after a stay at the intensive care unit (ICU) have been tested and implemented, but the effectiveness is inconclusive, and on relatives sparse. The aim is to determine whether relatives to former intensive care patients benefits from a recovery programme with improved health-related quality of life (HRQOL), Sense Of Coherence (SOC), and symptoms of anxiety, depression, and PTSD compared to standard care during the first year after ICU discharge.

This was a sub-study of the "Recovery and Aftercare in Post-Intensive care Therapy patients" (RAPIT) trial; a pragmatic, non-blinded, multicentre, parallel-group, randomized controlled trial. We recruited patients and relatives concurrently during the RAPIT-trial study-period, and now we are doing analysis on relatives. We wants to include adult relatives defined by the patients from 10 Danish ICUs.

The study was powered to detect an effect size of a 5-point increase in the Medical Health Survey Short-Form 36 (SF-36) on the mental component score (MCS) in the intervention group at 12 months post-ICU. Power calculation was based on an expected distribution of MCS from a matched population with a mean of 36.7 (SD 11.7) from a similar study. With a statistical power of 80% and significance level of 0.05, we estimated that 86 relatives were needed in each group to complete follow-up.

The statistical analysis plan was based on intention-to-treat (ITT) as was per protocol (PP) analysis and investigating difference between intervention and controls. Relatives were considered to have received the intervention if the patient attended at least one of the three consultations, which accounted for the PP analysis.

Study Type

Interventional

Enrollment (Actual)

181

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sjælland
      • Holbæk, Sjælland, Denmark, 4300
        • Holbæk Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older
  • Defined by the patients

Exclusion Criteria:

  • If the patients dropped out or died during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Relatives participated actively in the one out of three consultation conducted by trained study nurses at two months after intensive care superimposed on standard care.

Intervention (plus standard care)

  • Patients photographs during the ICU-stay,
  • Written information about life after ICU
  • First consultation face-to-face in hospital setting at three months after ICU
  • Visit ICU and photographs given
  • Consultations as needed
Other Names:
  • Standard care
No Intervention: Standard care
Relatives to former ICU patients, who had received standard care (SC) completed a questionnaire package at 3 and 12 months after the patient was discharged from intensive care. After enrollment were all contract handled by primary investigator.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental Component Score
Time Frame: 12 months after ICU
Health-related Quality of life using Short-form-36 questionnaire
12 months after ICU

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental Component Score
Time Frame: 3 months after ICU
Health-related Quality of life using Short-form-36 questionnaire
3 months after ICU
Physical Component Score
Time Frame: 3 months after ICU
Health-related Quality of life using Short-form-36 questionnaire
3 months after ICU
Physical Component Score
Time Frame: 12 months after ICU
Health-related Quality of life using Short-form-36 questionnaire
12 months after ICU
Anxiety
Time Frame: 3 months after ICU
Anxiety measured by Hospital Anxiety and Depression Scale (HADS)
3 months after ICU
Anxiety
Time Frame: 12 months after ICU
Anxiety measured by Hospital Anxiety and Depression Scale (HADS)
12 months after ICU
Depression
Time Frame: 3 months after ICU
Depression measured by Hospital Anxiety and Depression Scale (HADS)
3 months after ICU
Depression
Time Frame: 12 months after ICU
Depression measured by Hospital Anxiety and Depression Scale (HADS)
12 months after ICU
Post-traumatic stress Disorders
Time Frame: 3 months after ICU
Post-traumatic stress measured by the Harvard trauma Quesionnaire, ver. IV
3 months after ICU
Post-traumatic stress Disorders
Time Frame: 12 months after ICU
Post-traumatic stress measured by the Harvard trauma Quesionnaire, ver. IV
12 months after ICU
Sense of coherence
Time Frame: 3 months after ICU
Sense Of Coherence measured by the 13-item Orientation to Life questionnaire Questionnaire
3 months after ICU
Sense of coherence
Time Frame: 12 months after ICU
Sense Of Coherence measured by the 13-item Orientation to Life questionnaire Questionnaire
12 months after ICU

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2012

Primary Completion (Actual)

December 31, 2015

Study Completion (Actual)

March 6, 2018

Study Registration Dates

First Submitted

August 22, 2017

First Submitted That Met QC Criteria

August 24, 2017

First Posted (Actual)

August 29, 2017

Study Record Updates

Last Update Posted (Actual)

March 7, 2018

Last Update Submitted That Met QC Criteria

March 6, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 01863 HIH-2012-011
  • NCT-01721239 (Other Identifier: Registry Identifier of RAPIT-I on ClinicalTrials.gov)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Agreement of collaboration between sites have determinated that abstracts should be evaluated by the RAPIT-steering committee prior data are shared with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Relatives

Clinical Trials on Intervention

Subscribe